Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-European stocks post worst week since October on vaccine woes

Fri, 29th Jan 2021 08:20

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* STOXX 600 down 3% on the week

* Ericsson jumps on upbeat earnings

* H&M slides as it fears loss in Q1
(Updates to market close)

By Sruthi Shankar

Jan 29 (Reuters) - European stocks slid on Friday, recording
their worst weekly performance since October as concerns around
the slow rollout of COVID-19 vaccines mount, while a retail
trading frenzy led to volatility on Wall Street.

The benchmark STOXX 600 index closed 1.9% lower,
erasing all of January's gains and ending the week down 3.1%

Germany's DAX fell 1.7%, the UK's blue-chip FTSE
100 dropped 1.8% and U.S. stocks fell more than 1% after
underwhelming COVID-19 vaccine data from Johnson & Johnson
.

Concerns around the potential economic damage from a new
strain of the coronavirus in Europe and delays to vaccine
rollouts have dented sentiment in the past few days.

In the U.S., where the stock market enjoyed a stimulus-led
rally last year, volatility was seen following steep gains in
heavily shorted stocks, including Gamestop and AMC
Entertainment after retail traders piled in.

Europe's medicines regulator approved AstraZeneca
and Oxford University's COVID-19 vaccine for people over the age
of 18 on Friday, the third vaccine to be cleared for use in the
European Union.

Europe urgently needs more shots to speed up its inoculation
programme, with AstraZeneca, Pfizer and Moderna
facing difficulties in delivering the shipments to the bloc.

"We're postponing the recovery story a little bit because of
the lockdown measures and challenges for European growth," said
Joseph Little, global chief strategist at HSBC Global Asset
Management, London.

"I'm still optimistic on parts of Europe which have lagged
rather badly, economically and in markets. They could begin to
perform as the cyclical catch-up becomes more important."

Economy-linked stocks of banks, insurers,
miners and oil & gas companies were among the
worst hit this week but Germany and Spain's economies recorded
growth in the fourth quarter, while the French economy
contracted by a smaller than expected rate.

In a busy day for earnings, Sweden's Ericsson
jumped 7.6% after reporting fourth-quarter core earnings ahead
of market estimates on the back of strong sales of 5G equipment.

Daimler edged up 0.9% after it said a strong
fourth quarter helped it post better-than-expected 2020 group
operating profit and that it was optimistic for 2021.

Swedish fashion retailer H&M fell 5.0% as it braced
for a loss in the first quarter after full-year profits
plummeted due to COVID-19.

Europe's earnings season has been largely positive so far.
Of the 8% of STOXX 600 companies that have reported, 78% have
topped profit estimates, according to Refinitiv IBES data.
(Reporting by Sruthi Shankar in Bengaluru; editing by Bernard
Orr and Elaine Hardcastle)

More News
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.